Rabourn Amy Zaremba - Jan 18, 2024 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role: SVP of Finance
Signature: /s/ Emily Johns, by Power of Attorney
Stock symbol: OCUP
Transactions as of: Jan 18, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/22/2024, 06:01 PM
Previous filing: Jan 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+40K	+93.77%	$0.00	82.7K	Jan 18, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+60K		$0.00	60K	Jan 18, 2024	Common Stock	60K	$2.77	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 18, 2024.
F2	The option will vest with respect to 15,000 shares on January 18, 2025, with the balance vesting quarterly in twelve equal installments thereafter at the end of each quarter.